Eyal Rubin

Eyal Rubin

Direttore Finanziario/CFO presso NASUS PHARMA LTD.
49 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Eyal Rubin is Chief Financial Officer & Executive Vice President at Nasus Pharma Ltd. since 2025.
Former roles include CFO, Secretary, Treasurer & Senior Vice President at Protalix Biotherapeutics, Inc. from 2019 to 2025; Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2017 to 2019; Vice President & Head-Treasury at Teva Pharmaceutical Industries Ltd. from 2013 to 2017; Head-Finance & Banking Department at Cellcom Israel Ltd. from 2010 to 2013; Chief Financial Officer at Idt Carmel, Inc. from 2006 to 2010; Chief Financial Officer & General Manager at V-Secure Technologies, Inc. from 2003 to 2005; Chief Operating Officer & Vice President-Finance at Sec2Wireless, Inc. from 1999 to 2003.
Education includes an MBA from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.

Posizioni attive di Eyal Rubin

SocietàPosizioneInizio
NASUS PHARMA LTD. Direttore Finanziario/CFO 20/11/2025

Precedenti posizioni note di Eyal Rubin

SocietàPosizioneFine
PROTALIX BIOTHERAPEUTICS, INC. Direttore Finanziario/CFO 24/08/2025
BRAINSTORM CELL THERAPEUTICS INC. Direttore Finanziario/CFO 06/09/2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2017
CELLCOM ISRAEL LTD. Corporate Officer/Principal 01/03/2013
Idt Carmel, Inc.
Direttore Finanziario/CFO 01/01/2010
Vedi nel dettaglio l'esperienza di Eyal Rubin

Formazione di Eyal Rubin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

67

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Commercial Services

Communications

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Idt Carmel, Inc.

Health Technology

  1. Mercati
  2. Insiders
  3. Eyal Rubin